- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03550976
The Effect of Early Nutrition Intervention on the Incidence of High-risk Patients With Gestational Diabetes
August 6, 2018 updated by: Liuyanping, Peking Union Medical College Hospital
The incidence of gestational diabetes increased.The multidisciplinary management of GDM during pregnancy is helpful to improve the pregnancy outcome, but it will occupy huge medical resources.Early prediction, diet and exercise interventions can reduce the incidence of gestational diabetes, but there is no reliable way to predict and intervene early.This study is a randomized controlled trials, and aims to use comprehensive prediction method (genetic screening, body composition, clinical risk factors screening) screening the subjects with high GDM risk in early pregnancy, conducting diet and exercise intervention in second trimester and observing the effect on the incidence of GDM and perinatal outcomes.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
400
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- early pregnant women (< 12 weeks)
- fasting blood glucose < / = 5.6 mmol/L and glycosylated hemoglobin < / = 5.6%
- prepregnancy overweight (BMI > 23.9) or body fat content more than 30% (based on body composition analysis)
- no history of major diseases or long-term drug treatment
- no obvious physical disabilities, the ability of physical activity is normal
- dietary behavior and mental is normal
- resident in Beijing, early and middle stage pregnancy can be in Beijing area to receive regular obstetric examinations
- signed informed consent
the following at least one
- first-degree relatives family history of diabetes
- history of abnormal lipid metabolism or abnormal lipid metabolism
- history of polycystic ovary syndrome
- history of large for gestational age infant or macrosomia deliver
Exclusion Criteria:
- history of gestational diabetes mellitus
- clinical glucose metabolism abnormalities
- once taking diabetes drugs or insulin injections
- a variety of food allergies or food choices serious limitations
- exercise during pregnancy contraindication
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: High risk intervention group
|
During the 12-28 weeks of pregnancy, the pregnant women received low-GI diet and exercise intervention.Every two weeks, the pregnant women were followed up to assess the dietary situation and analyze the body composition results.Collect birth outcomes
|
|
NO_INTERVENTION: High risk control group
Dietary evaluation and body composition analysis at 12 and 28 weeks of pregnancy.
Receive routine obstetric examinations and routine health education which includes proper diet and exercise advice.Collect birth outcomes.
|
|
|
NO_INTERVENTION: Low risk control group
Dietary evaluation and body composition analysis at 12 and 28 weeks of pregnancy.
Receive routine obstetric examinations and routine health education which includes proper diet and exercise advice.Collect birth outcomes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of gestational diabetes
Time Frame: 12-28 weeks of pregnancy
|
The incidence of GDM was compared between the low-GI diet and the muscle training group, the high-risk control group and the low-risk control group.
|
12-28 weeks of pregnancy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
October 1, 2018
Primary Completion (ANTICIPATED)
September 10, 2019
Study Completion (ANTICIPATED)
June 1, 2020
Study Registration Dates
First Submitted
May 29, 2018
First Submitted That Met QC Criteria
May 29, 2018
First Posted (ACTUAL)
June 11, 2018
Study Record Updates
Last Update Posted (ACTUAL)
August 8, 2018
Last Update Submitted That Met QC Criteria
August 6, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- hs-1551
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gestational Diabetes
-
IRCCS Burlo GarofoloCompletedGestational Diabetes | Gestational Diabetes Mellitus | Pregnancy-Induced Diabetes | Diabetes Mellitus, Gestational | Diabetes, Pregnancy InducedIsrael, Italy, Netherlands, Slovenia, Sri Lanka
-
UPECLIN HC FM Botucatu UnespCompletedGestational Diabetes Mellitus | Pregestational Diabetes Mellitus | Mild Gestational HyperglycemiaBrazil
-
University of Tennessee Graduate School of MedicineRecruitingInsulin Resistance | Pregnancy Complications | Pregnancy | Preeclampsia | Gestational Diabetes | Gestational Diabetes Mellitus in Pregnancy | Placental Dysfunction | Gestational Diabetes Mellitus (GDM) | Preeclampsia (PE) | Cardiometabolic Diseases | Gestational Complications | Preeclampsia (PE) RiskUnited States
-
Woman'sBaton Rouge Area FoundationCompletedGestational Diabetes MellitusUnited States
-
Baylor College of MedicineRecruitingGestational Diabetes MellitusUnited States
-
Joslin Diabetes CenterRoche DiagnosticsCompletedGestational Diabetes MellitusUnited States
-
Ludwig-Maximilians - University of MunichGerman Federal Ministry of Education and Research; Helmholtz Zentrum MünchenCompletedGestational Diabetes MellitusGermany
-
Assiut UniversityUnknownGestational Diabetes Mellitus
-
Royal College of Surgeons, IrelandHealth Research Board - Trials Methodology Research NetworkCompletedPre-Gestational DiabetesIreland
-
University of Texas Southwestern Medical CenterCompletedMild Gestational DiabetesUnited States
Clinical Trials on The low-GI diet and muscle training
-
Ohio State UniversityCompletedGlucose Metabolism Disorders | Spinal Cord Injuries | Postprandial HypotensionUnited States
-
University of CopenhagenThe Danish Dairy Research Foundation, Denmark; Nordea-Fonden, Denmark; LEGO Charity... and other collaboratorsActive, not recruitingObesity | Pregnancy | Gestational Age and Weight Conditions | Maternal Care for Excessive Fetal Growth | Metabolic DisordersDenmark
-
Federal University of VicosaCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Fundação de Amparo...CompletedType 2 Diabetes MellitusBrazil
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Diseases | OverweightUnited States
-
Maastricht University Medical CenterUnilever R&DCompletedObesity | Diet, Healthy | Fatty Liver, NonalcoholicNetherlands
-
Chinese University of Hong KongCompletedObesity | Central ObesityHong Kong
-
University of TorontoCompletedGestational DiabetesCanada
-
Isfahan University of Medical SciencesCompletedDiabetic Nephropathy | Medication ComplianceIran, Islamic Republic of
-
University of Massachusetts, WorcesterCompletedLow-GI Dietary Education | ADA Dietary EducationUnited States
-
University Hospital of the West IndiesCompletedInflammation | Cardiovascular Disease | Type 2 DiabetesJamaica